:format(webp))
BALLERUP, DENMARK – GN today announced the global launch of a new, groundbreaking fitting software version 2.3.1 that proudly becomes the world's first to integrate NAL-NL3. Developed by the National Acoustic Laboratories (NAL), NAL-NL3 represents the next generation of hearing aid prescription formulas, designed for evidence-based, precise fittings.
With NAL-NL3 now available within new fitting software from GN, hearing care professionals can access a widely recognised gold standard in audiology. This advanced prescription formula leverages sophisticated AI insights and real-world user feedback, enabling highly precise and personalised hearing outcomes with greater consistency and confidence. GN also offers enhanced AutoREM (Real-Ear Measurement) to ensure the hearing aid's sound output precisely matches the user's specific ear acoustics for a more natural and comfortable listening experience.
Brent Edwards, Director of the National Acoustic LaboratoriesWe are incredibly excited that GN introduces the first fitting software to integrate NAL-NL3. This will enable hearing care professionals to harness the full power of our cutting-edge prescriptive formula, providing their patients with the most precise and personalised sound experience possible. It truly elevates the standard of care.
:format(webp))
Andreas Anderhov, Regional President of Asia-Pacific for GN Hearing, highlighted the impact: "This launch underscores GN's commitment to innovation built through partnership and clinical evidence. We are proud that the very first fitting with NAL-NL3 has successfully taken place at a Hearing Australia Clinic, the largest provider of government-funded hearing services in Australia. This achievement demonstrates our dedication to people-centred innovation."
GN’s new fitting software with NAL-NL3 will be available worldwide starting March 11, 2026, via a global software release of ReSound Smart Fit™ 2.3.1, Beltone Solus Max™ 2.3.1, and Hearing Australia Fitware 2.3.1.
SOURCE: GN Hearing
